1. Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions. Issue 43 (8th October 2019) Authors: Lopes, J.L.S.; Oliveira, D.C.A.; Utescher, C.L.A.; Quintilio, W.; Tenório, E.C.N.; Oliveira, C.L.P.; Fantini, M.C.A.; Rasmussen, M.K.; Bordallo, H.N.; Sant'Anna, O.A.; Botosso, V.F. Journal: Vaccine Issue: Volume 37:Issue 43(2019) Page Start: 6415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey. (17th September 2020) Authors: Loft, N.D.; Halling, A.‐S.; Iversen, L.; Vestergaard, C.; Deleuran, M.; Rasmussen, M.K.; Zachariae, C.; Thyssen, J.P.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 12(2020) Page Start: e773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Economic evaluations of interventions against viral pandemics: a scoping review. (July 2022) Authors: Rasmussen, M.K.; Kronborg, C.; Fasterholdt, I.; Kidholm, K. Journal: Public health Issue: Volume 208(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Localization of treatment‐resistant areas in patients with psoriasis on biologics. (1st August 2019) Authors: Hjuler, K.F.; Iversen, L.; Rasmussen, M.K.; Kofoed, K.; Skov, L.; Zachariae, C. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Localization of treatment‐resistant areas in patients with psoriasis on biologics. (7th May 2019) Authors: Hjuler, K.F.; Iversen, L.; Rasmussen, M.K.; Kofoed, K.; Skov, L.; Zachariae, C. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study. (12th April 2022) Authors: Loft, N.; Egeberg, A.; Rasmussen, M.K.; Bryld, L.E.; Nissen, C.V.; Dam, T.N.; Ajgeiy, K.K.; Iversen, L.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 8(2022) Page Start: 1284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Psoriatic epidermis expresses high level of inflammatory mediators and the CDK2/4 cyclin‐dependent kinases are involved in the regulation of cell‐cycle progression in epidermal cells. (11th December 2019) Authors: Gesser, B.; Rasmussen, M.K. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Psoriatic epidermis expresses high level of inflammatory mediators and the CDK2/4 cyclin‐dependent kinases are involved in the regulation of cell‐cycle progression in epidermal cells. (1st March 2020) Authors: Gesser, B.; Rasmussen, M.K. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (9th January 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗